| Views | |
|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 47 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of eltrombopag in patients with chronic immune thrombocytopenia: meta-analysis of randomized controlled trials | 2 | 11 | 6 | 9 | 4 | 7 | 0 |
| Views | |
|---|---|
| Pokrovskiy_Safety_21.pdf | 22 |
| Views | |
|---|---|
| United States | 13 |
| Canada | 5 |
| Brazil | 4 |
| France | 2 |
| India | 2 |
| Mongolia | 2 |
| Australia | 1 |
| China | 1 |
| Colombia | 1 |
| Japan | 1 |
| Views | |
|---|---|
| Ottawa | 4 |
| Houston | 2 |
| Mountain View | 2 |
| Nanterre | 2 |
| San Francisco | 2 |
| Ulaanbaatar | 2 |
| Aptos | 1 |
| Florianópolis | 1 |
| Kanda | 1 |
| Marijampole | 1 |